Twitxy
Saved
@DocJarad's profile picture
View on X

Prof Jarad Martin

@DocJarad

Radiation Oncologist who treats and researches #prostatecancer, gastrointestinal cancers & benign diseases. Dabbles in #mathematics. Views my own.
Newcastle, Australia scholar.google.com.au/citations?user… Joined May 2012
258 Following 1.6K Followers 1.1K Posts

Latest posts 5

Prof Jarad Martin @DocJarad
ProPSMA - the gift that keeps on giving! Great to be part of such an impactful collaboration.
Michael Hofman Verified account @DrMHofman Nov 29, 2024
Longer follow-up from our landmark ProPSMA study just out @EurUrolOncol:

PSMA nodal status is prognostic! At 3 years 70% of patients without nodal involvement (N0) disease free, vs. only 46% if N1

CT-defined nodal status is not prognostic.

Read the details here: authors.elsevier.com/sd/article/S25…

Super team: @declangmurphy @veerukasi @ButeauJames @lawrentschuk @mj_robbo @DocJarad @mfrydenberg @DrAIravani

ProPSMA sponsored by @PeterMacCC
Funded by @PCFA @MovemberAUS
@pros_tic supported by @PCF_Science
View quoted post on X
1 replies 2 reposts 17 likes 1.1K views View on X
Prof Jarad Martin @DocJarad
Brachytherapy doses of radiotherapy delivered non-invasively for prostate cancer with 94.1% 5-year control and low rates of significant toxicity. Now being investigated in randomised trials such as @TROGfightcancer NINJA and @GETUG_Unicancer PEACE 7.
European Urology Oncology Verified account @EurUrolOncol Oct 14, 2024
Prostate Virtual High-dose-rate Brachytherapy Boost: 5-Year Results from the PROMETHEUS Prospective Multicentre Trial by @drericwegener et al

buff.ly/3Nc1hC5

#UroSoMe #MedTwitter #EUO
View quoted post on X
0 replies 8 reposts 17 likes 2.5K views View on X
Prof Jarad Martin @DocJarad
I struggle with when to consider testosterone replacement for symptomatic men with controlled disease after ADT. After either six or 18 months of ADT, spontaneous recovery is rare after the two year mark, so some great data to inform shared decision making.
Amar Kishan Verified account @AmarUKishan Sep 21, 2024
Pleased to share the newest MARCAP publication, out in @EUplatinum -- the TRANSPORT analysis of T recovery after ADT for localized PCa, led by @weeloonong and Tahmineh Romero
Free share link: authors.elsevier.com/a/1joOX14kplyz…
View quoted post on X
2 replies 19 reposts 41 likes 7.4K views View on X
Prof Jarad Martin @DocJarad
Great to see vHDRB going mainstream. Here is our data for 20Gy/2# boost - 94% efficacy, and low toxicity. Experimental arm in ongoing RCTs NINJA and PEACE 7.
sciencedirect.com/science/articl…
Sean Collins Prostate SBRT @ USF Health @SbrtSean Jun 23, 2024
EBRT Plus Prostate SBRT Boost (19 Gy in 2 Fxs) has been Added to the NCCN Guidelines for Unfavorable Intermediate to Very High Risk Prostate Cancer!
View quoted post on X
1 replies 2 reposts 13 likes 1.6K views View on X
Prof Jarad Martin @DocJarad
Congratulations @_ShankarSiva. Super excited to have contributed to this important clinical trial, and looking forward to help roll renal #SBRT out as a standard management option for primary #RCC.
Shankar Siva Verified account @_ShankarSiva Feb 27, 2024
1/ For #KidneyCancerAwareness month @TheLancetOncol has a 50-day full link to @TROGfightcancer FASTRACK II! authors.elsevier.com/a/1ifvZ5EIIgPd…. Thank you @CancerAustralia, @ANZUPtrials, @VarianMedSys. A new #radiotherapy standard of care option for inoperable primary #kidneycancer #radonc
View quoted post on X